GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
27.67
-0.82 (-2.88%)
Jun 30, 2026, 2:30 PM EDT - Market open
GH Research Employees
GH Research had 73 employees as of December 31, 2025. The number of employees increased by 23 or 46.00% compared to the previous year.
Employees
73
Change (1Y)
23
Growth (1Y)
46.00%
Revenue / Employee
n/a
Profits / Employee
-$772,781
Market Cap
1.90B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 73 | 23 | 46.00% |
| Dec 31, 2024 | 50 | 1 | 2.04% |
| Dec 31, 2023 | 49 | 17 | 53.13% |
| Dec 31, 2022 | 32 | 18 | 128.57% |
| Dec 31, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Lakefront Biotherapeutics NV | 558 |
| Nuvation Bio | 307 |
| Syndax Pharmaceuticals | 298 |
| Viridian Therapeutics | 252 |
| Monte Rosa Therapeutics | 187 |
| Stoke Therapeutics | 170 |
| AtaiBeckley | 99 |
GHRS News
- 26 days ago - GH Research announces publication of Phase 2a results for mebufotenin - TheFly
- 26 days ago - GH Research Announces Publication of Phase 2a Postpartum Depression Results - GlobeNewsWire
- 6 weeks ago - GH Research price target lowered to $65 from $70 at H.C. Wainwright - TheFly
- 6 weeks ago - GH Research price target raised to $35 from $25 at Cantor Fitzgerald - TheFly
- 6 weeks ago - GH Research price target lowered to $39 from $42 at Citizens - TheFly
- 6 weeks ago - Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings - TheFly
- 6 weeks ago - GH Research Earnings release: Q1 2026 - Filings
- 6 weeks ago - GH Research files $400M mixed securities shelf - TheFly